PTEN is one of the most important tumor suppressors, mutated or deleted in nearly half of human cancers, including HCC patients [26] and changes in its expression have also been shown to regulate hepatic lipid metabolism and insulin sensitivity [23], [24], [25], [26]. This evidence concerns the gene PTEN and hepatocellular carcinoma.